BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 12953631)

  • 1. Melanoma: is immunotherapy of benefit?
    Faries MB; Morton DL
    Adv Surg; 2003; 37():139-69. PubMed ID: 12953631
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy for the management of advanced melanoma: the next steps.
    Zikich D; Schachter J; Besser MJ
    Am J Clin Dermatol; 2013 Aug; 14(4):261-72. PubMed ID: 23516145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma and immunotherapy.
    Eggermont AM; Schadendorf D
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for melanoma.
    Kim CJ; Dessureault S; Gabrilovich D; Reintgen DS; Slingluff CL
    Cancer Control; 2002; 9(1):22-30. PubMed ID: 11907463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination immunotherapy breakthrough for melanoma.
    Brower V
    Lancet Oncol; 2015 Jul; 16(7):e318. PubMed ID: 26062775
    [No Abstract]   [Full Text] [Related]  

  • 6. Metastatic melanoma - a review of current and future treatment options.
    Maverakis E; Cornelius LA; Bowen GM; Phan T; Patel FB; Fitzmaurice S; He Y; Burrall B; Duong C; Kloxin AM; Sultani H; Wilken R; Martinez SR; Patel F
    Acta Derm Venereol; 2015 May; 95(5):516-24. PubMed ID: 25520039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous melanoma: detecting it earlier, weighing management options.
    Lane JE; Dalton RR; Sangueza OP
    J Fam Pract; 2007 Jan; 56(1):18-28. PubMed ID: 17217894
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prognostic factors and improving treatment of cutaneous melanoma].
    Vihinen P; Kähäri VM; Pyrhönen S
    Duodecim; 2004; 120(12):1445-56. PubMed ID: 15293705
    [No Abstract]   [Full Text] [Related]  

  • 9. Is sentinel node status predictive of overall survival in patients with melanoma?
    Carlson GW
    Nat Clin Pract Oncol; 2005 Oct; 2(10):494-5. PubMed ID: 16205765
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant melanoma.
    Califano J; Nance M
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary treatment of primary melanoma.
    Yao K; Balch G; Winchester DJ
    Surg Clin North Am; 2009 Feb; 89(1):267-81, xi. PubMed ID: 19186240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood melanoma.
    Jen M; Murphy M; Grant-Kels JM
    Clin Dermatol; 2009; 27(6):529-36. PubMed ID: 19880040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rational surgical approach to the treatment of distant melanoma metastases.
    Martinez SR; Young SE
    Cancer Treat Rev; 2008 Nov; 34(7):614-20. PubMed ID: 18556133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome.
    Ridolfi L; Petrini M; Fiammenghi L; Granato AM; Ancarani V; Pancisi E; Brolli C; Selva M; Scarpi E; Valmorri L; Nicoletti SV; Guidoboni M; Riccobon A; Ridolfi R
    Melanoma Res; 2011 Dec; 21(6):524-9. PubMed ID: 21909041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome and immunotherapy response.
    Burki TK
    Lancet Oncol; 2017 Dec; 18(12):e717. PubMed ID: 29129446
    [No Abstract]   [Full Text] [Related]  

  • 16. Determinants of unfavorable presentation of primary cutaneous melanoma.
    Fallah M; Kharazmi E; Thomsen H; Sundquist J; Hemminki K
    J Am Acad Dermatol; 2011 Jul; 65(1):e5-6. PubMed ID: 21679807
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma.
    Ridolfi L; Ridolfi R; Riccobon A; De Paola F; Petrini M; Stefanelli M; Flamini E; Ravaioli A; Verdecchia GM; Trevisan G; Amadori D
    J Immunother; 2003; 26(2):156-62. PubMed ID: 12616107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines for melanoma.
    Bystryn JC
    Dermatol Clin; 2002 Oct; 20(4):717-25. PubMed ID: 12380059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma.
    Kalani AD; Jack A; Montenegro G; Degliuomini J; Wallack MK
    G Ital Dermatol Venereol; 2008 Feb; 143(1):59-70. PubMed ID: 18833052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma: non-metastatic.
    Crosby D; Crosby T; Mason M
    Clin Evid; 2002 Jun; (7):1519-29. PubMed ID: 12230768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.